GX-188
- Generic Name
- GX-188
The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer
- First Posted Date
- 2018-02-23
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Genexine, Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT03444376
- Locations
- 🇰🇷
Inje University Busan Paik Hospital, Busan, Korea, Republic of
🇰🇷Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of
🇰🇷Seoul National University Bundang Hospital, Gyeonggi-do, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath